GoodRx Holdings (GDRX) Retained Earnings (2019 - 2026)

GoodRx Holdings has disclosed Retained Earnings across 8 years of filings, most recently posting -$1.4 billion for Q2 2026.

• In Q2 2026, Retained Earnings rose 1.15% year-over-year to -$1.4 billion; the TTM figure through Jun 2026 stood at -$1.4 billion (up 1.15% YoY), while the FY2025 annual figure was -$1.4 billion, up 2.11% from the prior year.
• Retained Earnings came in at -$1.4 billion for Q2 2026 at GoodRx Holdings, up from -$1.4 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$1.4 billion in Q2 2023 to a low of -$1.5 billion in Q1 2024.
• Average Retained Earnings over 5 years is -$1.4 billion, with a median of -$1.4 billion recorded in 2023.
• Year-over-year, Retained Earnings retreated 5.14% in 2022 and rose 2.38% in 2025.
• Over 5 years, Retained Earnings stood at -$1.4 billion in 2022, then dropped by 0.61% to -$1.5 billion in 2023, then grew by 1.12% to -$1.4 billion in 2024, then climbed by 2.11% to -$1.4 billion in 2025, then grew by 0.69% to -$1.4 billion in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$1.4 billion in Q2 2026, -$1.4 billion in Q1 2026, and -$1.4 billion in Q4 2025.